Abstract
Objective: Advanced ovarian cancer is associated with a high rate of venous thromboembolism (VTE). The Khorana score is a validated measure that has been used to identify cancer patients at high risk for VTE. We sought to determine the utility of the Khorana score in predicting VTE in patients with advanced ovarian cancer during primary therapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
